盈康生命
(300143)
| 流通市值：50.99亿 | | | 总市值：50.99亿 |
| 流通股本：6.42亿 | | | 总股本：6.42亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 416,230,884.39 | 1,470,797,895.06 | 1,103,414,216.68 | 723,777,279.31 |
| 营业收入 | 416,230,884.39 | 1,470,797,895.06 | 1,103,414,216.68 | 723,777,279.31 |
| 利息收入 | - | - | 0 | - |
| 已赚保费 | - | - | 0 | - |
| 手续费及佣金收入 | - | - | 0 | - |
| 二、营业总成本 | 382,865,011.79 | 1,319,452,815.92 | 985,924,499.67 | 636,781,878.6 |
| 营业成本 | 304,853,668.78 | 1,050,533,271.16 | 774,821,694.75 | 497,885,143.57 |
| 利息支出 | - | - | 0 | - |
| 手续费及佣金支出 | - | - | 0 | - |
| 退保金 | - | - | 0 | - |
| 赔付支出净额 | - | - | 0 | - |
| 提取保险合同准备金净额 | - | - | 0 | - |
| 保单红利支出 | - | - | 0 | - |
| 分保费用 | - | - | 0 | - |
| 税金及附加 | 779,771.37 | 3,731,728.78 | 2,420,601.16 | 1,897,709.22 |
| 销售费用 | 17,094,740.99 | 63,211,833.69 | 47,180,551.49 | 33,095,744.75 |
| 管理费用 | 46,917,988.88 | 148,075,759.48 | 117,179,751.97 | 76,248,904.29 |
| 研发费用 | 13,073,292.94 | 52,238,723.57 | 42,555,359.64 | 27,248,171.01 |
| 财务费用 | 145,548.83 | 1,661,499.24 | 1,766,540.66 | 406,205.76 |
| 其中:利息费用 | 3,493,293.39 | 7,579,883.69 | 5,513,271.42 | 3,586,727.46 |
| 其中:利息收入 | 3,500,498.07 | 6,490,599.43 | 2,973,607.32 | 1,885,361.44 |
| 加:公允价值变动收益 | - | -3,135,839.28 | 0 | - |
| 加:投资收益 | 28,580.82 | 1,266,414.19 | 1,755,132.05 | 388,207.3 |
| 净敞口套期收益 | - | - | 0 | - |
| 汇兑收益 | - | - | 0 | - |
| 资产处置收益 | 297,314.63 | 43,674.4 | -108,747.3 | -108,747.3 |
| 资产减值损失(新) | - | -4,114,778.53 | -2,423,733.1 | -1,795,321.98 |
| 信用减值损失(新) | -3,026,574.95 | -16,749,199.68 | -2,288,413.45 | -749,230.82 |
| 其他收益 | 4,036,382.07 | 13,354,163.06 | 10,011,146.04 | 6,683,620.73 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 34,701,575.17 | 142,009,513.3 | 124,435,101.25 | 91,413,928.64 |
| 加:营业外收入 | 143,384.65 | 5,412,845.96 | 2,769,043.56 | 2,656,251.13 |
| 减:营业外支出 | 672,261.94 | 15,900,646.28 | 6,458,206.12 | 4,353,606.41 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 34,172,697.88 | 131,521,712.98 | 120,745,938.69 | 89,716,573.36 |
| 减:所得税费用 | 8,115,539.45 | 32,323,211.26 | 28,568,472.39 | 19,438,983.89 |
| 六、净利润 | 26,057,158.43 | 99,198,501.72 | 92,177,466.3 | 70,277,589.47 |
| 持续经营净利润 | 26,057,158.43 | 99,198,501.72 | 92,177,466.3 | 70,277,589.47 |
| 终止经营净利润 | - | - | 0 | - |
| 归属于母公司股东的净利润 | 26,225,857.82 | 100,436,255.25 | 94,054,908.51 | 70,660,030.21 |
| 少数股东损益 | -168,699.39 | -1,237,753.53 | -1,877,442.21 | -382,440.74 |
| (一)基本每股收益 | 0.04 | 0.16 | 0.16 | 0.12 |
| (二)稀释每股收益 | 0.04 | 0.16 | 0.16 | 0.12 |
| 八、其他综合收益 | 10,995.46 | 109,556.83 | -1,699,207.76 | 336,385.36 |
| 归属于母公司股东的其他综合收益 | 10,995.46 | 109,556.83 | -1,699,207.76 | 336,385.36 |
| 九、综合收益总额 | 26,068,153.89 | 99,308,058.55 | 90,478,258.54 | 70,613,974.83 |
| 归属于母公司股东的综合收益总额 | 26,236,853.28 | 100,545,812.08 | 92,355,700.75 | 70,996,415.57 |
| 归属于少数股东的综合收益总额 | -168,699.39 | -1,237,753.53 | -1,877,442.21 | -382,440.74 |
| 公告日期 | 2024-04-26 | 2024-04-22 | 2023-10-27 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |